BIOSYNEX (EPA:ALBIO) | WebDisclosure

Basculer en Français

11080	Companies
243102	Keywords
171244	Articles
130863	Press releases

Home
Companies
BIOSYNEX

BRIEF

published on 07/29/2025 at 18:50, 1 year 1 month ago

Biosynex Achieves Breakthrough Device Status for Its Syphilis Test

FDA Syphilis Breakthrough Device Rapid Diagnosis Chembio
PRESS RELEASE

published on 07/29/2025 at 18:45, 1 year 1 month ago

BIOSYNEX SA: LA FOOD AND DRUG ADMINSITRATION ATTRIBUE LE STATUT “BREAKTHROUGH DEVICE” (PRODUIT NOVATEUR) AU TEST DPP® SYPHILIS TNT
La Food and Drug Administration attribue le statut de "breakthrough device" au test DPP® Syphilis TNT de Biosynex, développé par Chembio Diagnostic Systems, Inc

FDA BIOSYNEX Breakthrough Device Test DPP® Syphilis TNT Chembio Diagnostic Systems
BRIEF

published on 07/17/2025 at 18:05, 1 year 2 months ago

BIOSYNEX announces a decline in revenue for the first half of 2025

Restructuring Product Launches Turnover BIOSYNEX First Half Of 2025
BRIEF

published on 07/17/2025 at 18:05, 1 year 2 months ago

BIOSYNEX annonce un chiffre d'affaires en baisse pour le premier semestre 2025

Chiffre D'affaires Restructuration BIOSYNEX Lancements De Produits Premier Semestre 2025
PRESS RELEASE

published on 07/17/2025 at 18:00, 1 year 2 months ago

BIOSYNEX SA: CHIFFRE D’AFFAIRES DU PREMIER SEMESTRE 2025 : 50,8 M€ (-6%)
BIOSYNEX SA annonce un chiffre d'affaires de 50,8 M€ au premier semestre 2025, en baisse de 6%. Perspectives d'amélioration de l'EBE et de lancements de produits

Chiffre D'affaires Restructuration BIOSYNEX SA Lancements De Produits Premier Semestre 2025
BRIEF

published on 05/06/2025 at 15:15, 1 year 4 months ago

BIOSYNEX: Nombre d'Actions et Droits de Vote au 28 Février 2025

Droits De Vote Capital Social Euronext Growth BIOSYNEX Diagnostic Santé
BRIEF

published on 05/06/2025 at 15:15, 1 year 4 months ago

BIOSYNEX: Number of Shares and Voting Rights as of February 28, 2025

Share Capital Voting Rights Euronext Growth BIOSYNEX Health Diagnosis
PRESS RELEASE

published on 05/06/2025 at 15:10, 1 year 4 months ago

BIOSYNEX SA: DECLARATION DU NOMBRE D’ACTIONS ET DES DROITS DE VOTE AU 28 FEVRIER 2025
Déclaration du nombre d'actions et des droits de vote au 28 février 2025 par BIOSYNEX, Groupe leader du diagnostic de santé, spécialisé dans les tests rapides et la biologie moléculaire

Déclaration Droits De Vote Actions BIOSYNEX Diagnostic De Santé
BRIEF

published on 04/23/2025 at 18:05, 1 year 5 months ago

BIOSYNEX SA: 2024 Results and 2025 Reorganization Plan

Financial Structure BIOSYNEX SA 2024 Results Export Growth Reorganization 2025
BRIEF

published on 04/23/2025 at 18:05, 1 year 5 months ago

BIOSYNEX SA : Résultats 2024 et Plan de Réorganisation 2025

Structure Financière Résultats 2024 BIOSYNEX SA Réorganisation 2025 Croissance Export

Accesswire

Published on 09/24/2026 at 22:01, 1 hour 9 minutes ago

Fermi Selects CBRE to Operate and Maintain Its First Data Center
Published on 09/24/2026 at 17:45, 5 hours 25 minutes ago

Jo-Jo Announces Resignation of Director
Published on 09/24/2026 at 14:55, 8 hours 15 minutes ago

Nextech3D.ai Surpasses $1 Million in New Customer Contract Value, Expands AI Software Portfolio with KATE and Grows Multi-Year Enterprise Agreements
Published on 09/24/2026 at 14:30, 8 hours 40 minutes ago

Solitario Resources CEO to Present at the 38th Annual Mining Forum Americas 2026 Conference
Published on 09/24/2026 at 14:00, 9 hours 10 minutes ago

Horizon Aircraft to Report First Quarter 2027 Results and Provide a Business Update on October 9, 2026

View all ACCESSWIRE

EQS Group

Published on 09/24/2026 at 20:29, 2 hours 41 minutes ago

EQS-Adhoc: HelloFresh SE expects revenue for Q3 2026 below market expectations and adjusts outlook for the financial year 2026
Published on 09/24/2026 at 19:00, 4 hours 10 minutes ago

HIAG provides a first-hand insight into its strategy and the added value it generates at its Capital Market Day
Published on 09/24/2026 at 18:40, 4 hours 29 minutes ago

EQS-Adhoc: Brockhaus Technologies AG launches public share buyback offer of approx. €90 million for up to 3,592,000 shares
Published on 09/24/2026 at 18:15, 4 hours 55 minutes ago

Epanko Value Engineering Identifies 20% Production Increase
Published on 09/24/2026 at 18:05, 5 hours 4 minutes ago

DCK Tools Showcases Expanded Outdoor Power Equipment Lineup at Salonvert 2026

Les Echos

Published on 09/24/2026 at 18:31, 4 hours 38 minutes ago

LNA SANTE : Mise à disposition du rapport financier semestriel 2026
Published on 09/24/2026 at 18:10, 5 hours ago

Financial statements - 30 june 2026
Published on 09/24/2026 at 18:00, 5 hours 10 minutes ago

GUILLEMOT CORPORATION: Availability of the interim financial report to June 30, 2026
Published on 09/24/2026 at 18:00, 5 hours 10 minutes ago

GUILLEMOT CORPORATION : Mise à disposition du rapport financier semestriel au 30 juin 2026
Published on 09/24/2026 at 18:00, 5 hours 10 minutes ago

i2S : Résultats 1er semestre 2026

View all LES ECHOS COMFI WIRE